Marvella Ford to Mass Screening
This is a "connection" page, showing publications Marvella Ford has written about Mass Screening.
Connection Strength
1.077
-
Effects of baseline comorbidities on cancer screening trial adherence among older African American men. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1234-9.
Score: 0.196
-
Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. Gerontologist. 2006 Aug; 46(4):545-50.
Score: 0.173
-
Factors influencing behavioral intention regarding prostate cancer screening among older African-American men. J Natl Med Assoc. 2006 Apr; 98(4):505-14.
Score: 0.169
-
Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):190-4.
Score: 0.155
-
Design of a case management approach to enhance cancer screening trial retention among older African American men. J Aging Health. 2004 Nov; 16(5 Suppl):39S-57S.
Score: 0.153
-
Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist. 2003 Feb; 43(1):27-35.
Score: 0.136
-
Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Med Assoc. 2008 Mar; 100(3):291-8.
Score: 0.048
-
Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000 Dec; 21(6 Suppl):379S-389S.
Score: 0.029
-
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat. 2013 Jan; 137(2):589-98.
Score: 0.017